Influx Healthtech IPO Details
| IPO Open Date: | June 18, 2025 |
| IPO Close Date: | June 20, 2025 |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹91 to ₹96 Per Share |
| Issue Size: | Approx ₹58.57 Crores |
| Fresh Issue: | Approx ₹48.00 Crores |
| Offer for Sale: | Approx 11,00,400 Equity Shares |
| Issue Type: | Book Build Issue |
| IPO Listing: | NSE SME |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |
Influx Healthtech IPO Market Lot
The Influx Healthtech IPO minimum market lot is 1200 shares with ₹1,15,200 application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 1200 | ₹1,15,200 |
| Retail Maximum | 1 | 1200 | ₹1,15,200 |
| S-HNI Minimum | 2 | 2,400 | ₹2,30,400 |
Influx Healthtech IPO Dates
The Influx Healthtech IPO date is June 18 and the close date is June 20. The Influx Healthtech IPO allotment will be finalized on June 23 and the IPO listing on June 25.
| IPO Open Date: | June 18, 2025 |
| IPO Close Date: | June 20, 2025 |
| Basis of Allotment: | June 23, 2025 |
| Refunds: | June 24, 2025 |
| Credit to Demat Account: | June 24, 2025 |
| IPO Listing Date: | June 25, 2025 |
Promoters of Influx Healthtech IPO
The promoters of the company are Mr. Munir Abdul Ganee Chandniwala, Mrs. Shirin Munir Ahmed Chandniwala and Mr. Abdul Ganee Abdul Rasul Chandniwala.
About Influx Healthtech IPO
Influx Healthtech Limited, founded in 2020, is a leading healthcare-focused company specializing in contract manufacturing. The company has built a strong reputation as a trusted Contract Development and Manufacturing Organization (CDMO), offering expert services to clients from various industries. The company comprises manufacturing units in Thane, Maharashtra, with areas of around 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft. The company is known to manufacture its products while keeping safety, quality, and compliance with regulations. Influx Healthcare works in different areas like dietary and nutritional supplements, cosmetics, ayurvedic/herbal products, veterinary feed supplements, and homecare items. The CDMO business caters to many major clients like Bling Brands, Pursuit of Wellness, Aarkios Health, HSHS Nutraceuticals Limited, Novus Life Science, Bruder Life Science, Fredun Pharmaceuticals, and BigFlex Lifescience. As of now, the company includes 165 permanent staff.
Influx Healthtech IPO Company Financial Report
The company reported revenue of ₹104.99 crores in 2025 against ₹100.10 crore in 2024. The company reported profit of ₹13.37 crores in 2025 against profit of ₹11.22 crores in 2024.
Amount ₹ in Crores
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
| 2023 | ₹76.06 | ₹66.32 | ₹7.20 | ₹28.30 |
| 2024 | ₹100.02 | ₹85.08 | ₹11.13 | ₹41.10 |
| 2025 | ₹104.99 | ₹87.11 | ₹13.37 | ₹70.30 |
Influx Healthtech IPO Valuation – FY2025
Check Influx Healthtech IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 36.98% |
| ROCE: | 49.17% |
| EBITDA Margin: | 19.62% |
| PAT Margin: | 12.75% |
| Debt to equity ratio: | 0.01 |
| Earning Per Share (EPS): | ₹7.36 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 36.98% |
| Net Asset Value (NAV): | ₹19.91 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Sudarshan Pharma Industries Limited | 0.66 | 48.28 | 12.45% | 5.30 | 505.38 Cr. |
| Quest Laboratories Limited | 8.28 | 10.38 | 16.58% | 49.92 | 108.16 Cr. |
Objects of the Issue
- Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division
- Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division
- Purchase of Machineries for Homecare and Cosmetic Division
- General corporate purposes.
Influx Healthtech IPO Review
- IPO Watch – May Apply
- Canara Bank –
- DRChoksey FinServ –
- Emkay Global –
- Hem Securities –
- IDBI Capital –
- Marwadi Shares –
- Nirmal Bang –
- SBICAP Securities –
- Sharekhan –
- SMC Global –
- Sushil Finance –
- Swastika Investmart –
- Ventura Securities –
- Geojit –
- Reliance Securities –
- Capital Market –
- BP Wealth –
- ICICIdirect –
- Choice Broking –
Influx Healthtech IPO Registrar
Maashitla
Securities
Private
Limited
Phone:
+91-11-45121795-96
Email:
[email protected]
Website:
https://maashitla.com/allotment-status/public-issues
IPO Lead Managers aka Merchant Bankers
- Rarever Financial Advisors Pvt. Ltd. Pvt. Ltd.
Company Address
Influx
Healthtech
Limited
109,
Ghanshyam
Enclave
Premises
Co-op
Soc
Plot
No.
856,
Laljipada
Kandivali
West,
Mumbai, Maharashtra
Phone: +91
7045997809
Email: [email protected]
Website: https://influxhealthtech.com/
Influx Healthtech IPO FAQs
What is Influx Healthtech IPO?
When Influx Healthtech IPO will open for subscription?
What is Influx Healthtech IPO Investors Portion?
How to Apply the Influx Healthtech IPO?
What is Influx Healthtech IPO Issue Size?
What is Influx Healthtech IPO Price Band?
What is Influx Healthtech IPO Lot Size?
What is the Influx Healthtech IPO Allotment Date?
What is the Influx Healthtech IPO Listing Date?
Note: The Influx Healthtech IPO price band and date are officially announced. The (Influx Healthtech IPO grey market premium) will be added to the IPO GMP page as it will start).
